Ovation Science Announces License Agreement for Its Topical / Transdermal Cannabis Products for Missouri
VANCOUVER, BC and LAS VEGAS, Nov. 2, 2023 /PRNewswire/ - (CSE: OVAT) (OTCQB: OVATF) – Ovation Science USA Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, today announced the signing of an exclusive licensing agreement for Ovation's topical / transdermal formulations for the state of Missouri.
- VANCOUVER, BC and LAS VEGAS, Nov. 2, 2023 /PRNewswire/ - (CSE: OVAT) (OTCQB: OVATF) – Ovation Science USA Inc. ("Ovation" or the "Company"), with its proprietary topical and transdermal cannabis products powered by its patented skin delivery technology Invisicare®, today announced the signing of an exclusive licensing agreement for Ovation's topical / transdermal formulations for the state of Missouri.
- The Company's new licensee is MidWest Roots, LLC ("MidWest"); a company with a 65,000 square foot cannabis processing facility; one of the largest in Missouri.
- "We are excited to partner with MidWest to bring our innovative topical cannabis products to the Missouri market, said Terry Howlett, President of Ovation.
- In a recent in-house study, Ovation compared five CBD brand leaders to Ovation Science's topical CBD cream.